陕西农村地区儿童幽门螺杆菌感染的危险因素调查及与慢性肠系膜淋巴结炎的相关性研究

狄佳, 吴涛, 吴金鑫, 等. 陕西农村地区儿童幽门螺杆菌感染的危险因素调查及与慢性肠系膜淋巴结炎的相关性研究[J]. 中国中西医结合消化杂志, 2024, 32(6): 518-525. doi: 10.3969/j.issn.1671-038X.2024.06.12
引用本文: 狄佳, 吴涛, 吴金鑫, 等. 陕西农村地区儿童幽门螺杆菌感染的危险因素调查及与慢性肠系膜淋巴结炎的相关性研究[J]. 中国中西医结合消化杂志, 2024, 32(6): 518-525. doi: 10.3969/j.issn.1671-038X.2024.06.12
DI Jia, WU Tao, WU Jinxin, et al. Risk factor analysis of pediatric Helicobacter pylori infection of rural areas in Shaanxi Province and its correlation with chronic mesenteric lymphadenitis[J]. Chin J Integr Tradit West Med Dig, 2024, 32(6): 518-525. doi: 10.3969/j.issn.1671-038X.2024.06.12
Citation: DI Jia, WU Tao, WU Jinxin, et al. Risk factor analysis of pediatric Helicobacter pylori infection of rural areas in Shaanxi Province and its correlation with chronic mesenteric lymphadenitis[J]. Chin J Integr Tradit West Med Dig, 2024, 32(6): 518-525. doi: 10.3969/j.issn.1671-038X.2024.06.12

陕西农村地区儿童幽门螺杆菌感染的危险因素调查及与慢性肠系膜淋巴结炎的相关性研究

  • 基金项目:
    中国博士后科学基金面上项目(No:2022M712556);陕西省自然科学基金基础研究计划青年项目(No:2022JQ-838);西安交通大学第二附属医院医疗新技术基金(No:XJEFY-015)
详细信息

Risk factor analysis of pediatric Helicobacter pylori infection of rural areas in Shaanxi Province and its correlation with chronic mesenteric lymphadenitis

More Information
  • 目的 调查陕西农村地区儿童幽门螺杆菌(Helicobacter pylori,HP)感染的流行病学特征及筛选独立危险因素,并探讨HP感染与慢性肠系膜淋巴结炎(mesenteric lymphadenitis,MLN)的关系。方法 收集2020年9月—2023年10月就诊于西安交通大学第二附属医院、陕西子洲县中医院、陕西勉县中医院进行13C尿素呼气试验儿童的临床资料,完成HP感染基本情况分析、HP感染与慢性MLN患病特点分析、HP感染危险因素logistic回归分析、HP感染与慢性MLN相关性logistic回归分析。结果 本研究共纳入陕西省北、中、南部农村地区儿童709例,其中HP阳性329例,阴性380例,HP感染率为46.40%;慢性MLN患儿112例,无慢性MLN 597例,MLN患病率为15.80%。HP感染基本情况分析显示,各年龄段HP感染率比较均差异有统计学意义(均P < 0.001),>15~18岁儿童HP感染率最高;男童HP感染率显著高于女童,差异有统计学意义(P < 0.01);西安市农村地区儿童HP感染率显著高于榆林市及汉中市,均差异有统计学意义(均P < 0.01);共用刷牙口杯、共用餐具、无饭前便后洗手习惯、喜食零食、直系亲属有胃肠病史及家庭人口≥4人的儿童HP感染率均显著高于无上述习惯的儿童(均P < 0.001)。HP感染与慢性MLN患病特点分析显示,HP感染患儿的白细胞计数、单核细胞计数、C反应蛋白、降钙素原、IL-6、免疫球蛋白G、补体C3、补体C4显著升高,CD3+计数、CD4+计数、CD8+计数显著降低(均P < 0.05);紫癜患儿HP感染率显著高于贫血与口腔溃疡患儿(均P < 0.05);HP感染患儿腹腔淋巴结最大短径、肠壁水肿及腹腔液性暗区深度显著增加(均P < 0.01);慢性MLN患儿C反应蛋白、降钙素原、免疫球蛋白G、补体C3、补体C4、CD4+计数、CD8+计数、CD4+/ CD8+比值显著高于无慢性MLN儿童(均P < 0.05);贫血、口腔溃疡、发育缓慢患儿的MLN患病率相当,并显著高于其他患儿,均差异有统计学意义(均P < 0.05);慢性MLN患儿的腹腔淋巴结最大长径显著增加,高于无慢性MLN儿童,差异有统计学意义(P < 0.01)。HP感染危险因素logistic回归分析显示,性别、居住地区、共用餐具、无饭前便后洗手习惯、喜食零食、再发性腹痛及消化不良症状均为HP感染的独立危险因素(均P < 0.05)。HP感染与慢性MLN相关性的logistic回归分析显示,未校正模型HP感染与慢性MLN之间的比值比(OR)为2.324(95%CI:1.427~3.785,P < 0.001);当校正年龄、性别、居住地区、共用刷牙口杯、共用餐具、喜食零食、恶心及呕吐症状后,OR为2.352(95%CI:1.501~3.686,P < 0.001)。结论 陕西农村地区儿童HP感染的独立危险因素为性别、居住地区、共用餐具、无饭前便后洗手习惯、喜食零食、再发性腹痛及消化不良症状。HP感染是导致陕西农村地区儿童慢性MLN的重要危险因素。
  • 加载中
  • 图 1  陕西省农村地区儿童HP感染率的年龄分布图

    表 1  陕西农村地区儿童HP感染的基本情况 例(%)

    基本情况 合计 HP阳性(n=329) HP阴性(n=380) χ2 P
    年龄/岁 59.891 < 0.001
      4~6 123(17.35) 39(5.50) 84(11.85)
      >6~9 189(26.66) 71(10.01) 118(16.64)
      >9~12 176(24.82) 75(10.58) 101(14.25)
      >12~15 97(13.68) 51(7.19) 46(6.49)
      >15~18 124(17.49) 93(13.12) 31(4.37)
    性别 7.493 0.006
      男 379(53.46) 194(27.36) 185(26.09)
      女 330(46.54) 135(19.04) 195(27.50)
    居住地区 12.378 0.002
      榆林市(北) 203(28.63) 107(15.09) 96(13.54)
      西安市(中) 326(45.98) 128(18.05) 198(27.93)
      汉中市(南) 180(25.39) 94(13.26) 86(12.13)
    生活习惯
      共用刷牙口杯 29.582 < 0.001
        是 113(15.94) 26(3.67) 87(12.27)
        否 596(84.06) 303(42.74) 293(41.33)
      共用餐具 40.090 < 0.001
        是 589(83.07) 305(43.02) 284(40.06)
        否 120(16.93) 24(3.39) 96(13.54)
      饭前便后洗手 42.096 < 0.001
        是 547(77.15) 290(40.90) 257(36.25)
        否 162(22.85) 39(5.50) 123(17.35)
      喜食零食 47.981 < 0.001
        是 538(75.88) 289(40.76) 249(35.12)
        否 171(24.12) 40(5.64) 131(18.48)
      直系亲属有胃肠疾病史 28.520 < 0.001
        是 161(22.71) 45(6.35) 116(16.36)
        否 548(77.29) 284(40.06) 264(37.24)
      家庭人口/人 13.469 < 0.001
        ≥4 664(93.65) 320(45.13) 344(48.52)
        < 4 45(6.35) 9(1.27) 36(5.08)
    临床症状 4.034 0.672
      再发性腹痛 61(8.60) 38(5.36) 23(3.24)
      黑便 3(0.42) 2(0.28) 1(0.14)
      恶心 18(2.54) 13(1.83) 5(0.71)
      呕吐 19(2.68) 14(1.97) 5(0.71)
      消化不良 48(6.77) 35(4.94) 13(1.83)
      腹泻 5(0.71) 3(0.42) 2(0.28)
      湿疹 21(2.96) 11(1.55) 10(1.41)
    下载: 导出CSV

    表 2  HP感染与慢性MLN的患病特点 X ± S,例(%)

    患病特点 HP阳性(n=329) HP阴性(n=380) P 慢性MLN(n=112) 无慢性MLN(n=597) P
    检验指标
      白细胞计数/(×109/L) 7.76±2.76 7.34±2.86 0.047 7.57±2.85 7.48±2.62 0.756
      中性粒细胞计数/(×109/L) 4.42±2.58 4.29±2.49 0.497 4.36±2.56 4.32±2.41 0.878
      淋巴细胞计数/(×109/L) 2.64±1.27 2.55±1.64 0.420 2.61±1.52 2.53±1.02 0.486
      单核细胞计数/(×109/L) 0.51±0.36 0.45±0.25 0.009 0.49±0.33 0.44±0.25 0.068
      中性粒细胞百分比/% 57.54±26.65 55.38±14.54 0.191 56.44±22.23 56.25±13.79 0.905
      淋巴细胞百分比/% 35.49±14.25 35.42±13.59 0.947 36.44±13.13 35.29±14.07 0.423
      单核细胞百分比/% 6.39±2.41 6.20±2.57 0.310 6.37±2.50 5.89±2.41 0.061
      中性粒细胞/淋巴细胞比值 2.28±1.40 2.15±1.94 0.313 2.24±1.26 2.07±1.77 0.333
      C反应蛋白/(mg/L) 7.26±2.61 6.08±1.02 < 0.001 8.20±3.51 6.47±1.45 < 0.001
      降钙素原/(ng/mL) 0.18±0.15 0.14±0.13 < 0.001 0.19±0.15 0.13±0.09 < 0.001
      IL-6/(pg/mL) 9.41±5.28 7.14±1.92 < 0.001 7.69±5.36 7.44±1.30 0.624
      免疫球蛋白G/(g/L) 431.13±51.36 319.94±53.29 < 0.001 317.45±47.00 304.48±41.85 0.007
      补体C3/(g/L) 58.50±8.57 47.93±6.21 < 0.001 64.36±6.45 53.49±5.98 < 0.001
      补体C4/(g/L) 14.05±4.92 9.50±1.24 < 0.001 12.87±1.23 12.22±1.43 < 0.001
      CD3+计数/(细胞/μL) 1 000.77±825.75 1 487.03±933.77 < 0.001 1 023.00±755.58 956.98±736.79 0.386
      CD4+计数/(细胞/μL) 598.29±403.12 855.57±406.24 < 0.001 859.00±309.71 659.22±423.16 < 0.001
      CD8+计数/(细胞/μL) 419.22±292.57 636.00±440.13 < 0.001 575.50±283.55 486.16±368.50 0.004
      CD4+/CD8+ 1.47±0.53 1.53±0.45 0.108 1.55±0.22 1.48±0.52 0.019
    合并疾病 0.045 0.024
      贫血 16(2.26) 14(1.97) 4(0.56) 26(3.67)
      紫癜 21(2.96) 1(0.14) 3(0.42) 19(2.68)
      口腔溃疡 4(0.56) 3(0.42) 4(0.56) 3(0.42)
      腐蚀性食管炎 3(0.42) 1(0.14) 2(0.28) 2(0.28)
      肠梗阻 2(0.28) 1(0.14) 1(0.14) 2(0.28)
      发育缓慢 5(0.71) 2(0.28) 4(0.56) 3(0.42)
    腹部超声/mm
      淋巴结最大长径 14.29±4.72 13.72±4.01 0.083 16.23±4.15 14.19±4.60 < 0.001
      淋巴结最大短径 5.57±1.75 5.11±2.10 0.002 5.78±1.91 5.49±1.81 0.123
      肠壁水肿 21.33±9.82 19.67±4.16 0.003 21.21±5.76 21.00±8.87 0.749
      腹腔液性暗区深度 3.41±0.90 2.98±0.88 < 0.001 3.45±0.79 3.30±0.89 0.096
    胃镜检查 0.008 0.153
      食管炎 7(0.99) 6(0.85) 2(0.28) 11(1.55)
      慢性浅表性胃炎 71(10.01) 95(13.40) 74(10.44) 92(12.98)
      胃溃疡 2(0.28) 1(0.14) 1(0.14) 2(0.28)
      十二指肠溃疡 8(1.13) 1(0.14) 4(0.56) 5(0.71)
      十二指肠球炎 9(1.27) 1(0.14) 2(0.28) 8(1.13)
      胆汁反流 7(0.99) 6(0.85) 3(0.42) 10(1.41)
    下载: 导出CSV

    表 3  陕西农村地区儿童HP感染危险因素logistic回归分析

    高危因素 χ2 SE Wald χ2 P OR 95%CI
    年龄 -1.117 0.332 11.314 0.001 0.327 0.171~0.627
    性别 0.459 0.185 6.137 0.013 1.583 1.101~2.276
    居住地区 1.039 0.309 11.296 0.001 2.827 1.542~5.183
    共用刷牙口杯 -1.046 0.275 14.457 < 0.001 0.351 0.205~0.602
    共用餐具 1.216 0.287 17.900 < 0.001 3.375 1.921~5.929
    无饭前便后洗手习惯 1.085 0.239 20.613 < 0.001 2.960 1.853~4.730
    喜食零食 1.230 0.232 28.198 < 0.001 3.420 2.172~5.385
    直系亲属有胃肠疾病史 -0.890 0.236 14.234 < 0.001 0.410 0.258~0.652
    家庭人口≥4人 0.600 0.506 1.409 0.235 1.822 0.676~4.910
    再发性腹痛 0.867 0.350 6.149 0.013 2.380 1.199~4.724
    恶心 1.115 0.635 3.082 0.079 3.051 0.878~10.597
    呕吐 1.251 0.676 3.425 0.064 3.495 0.929~13.154
    消化不良 0.809 0.393 4.229 0.040 2.245 1.039~4.851
    下载: 导出CSV

    表 4  HP感染与慢性MLN相关性的logistic回归分析 OR(95%CI)

    13C-尿素呼气试验 模型1 模型2 模型3 模型4
    HP阴性 1.000(~) 1.000(~) 1.000(~) 1.000(~)
    HP阳性 2.324(1.427~3.785) 2.333(1.451~3.754) 2.319(1.477~3.639) 2.352(1.501~3.686)
    P 0.001 < 0.001 < 0.001 < 0.001
    下载: 导出CSV
  • [1]

    FitzGerald R, Smith M. An Overview of Helicobacter pylori Infection[J]. Methods Mol Biol, 2021, 2283: 1-14.

    [2]

    Malfertheiner P, Camargo C, El-Omar E, et al. Helicobacter pylori infection[J]. Nat Rev Dis Primers, 2023, 9(1): 19. doi: 10.1038/s41572-023-00431-8

    [3]

    Rowland M, Clyne M, Daly L, et al. Long-term follow-up of the incidence of Helicobacter pylori[J]. Clin Microbiol Infect, 2018, 24(9): 980-984. doi: 10.1016/j.cmi.2017.10.020

    [4]

    曹鑫, 王晓勇, 蒋逸舟, 等. 幽门螺杆菌根除对2型糖尿病患者血糖控制的影响研究进展[J]. 大连医科大学学报, 2023, 45(4): 349-353. https://www.cnki.com.cn/Article/CJFDTOTAL-DLYK202304013.htm

    [5]

    Zhang Y, Dong Q, Tian L, et al. Risk factors for recurrence of Helicobacter pylori infection after successful eradication in Chinese children: A prospective, nested case-control study[J]. Helicobacter, 2020, 25(5): e12749. doi: 10.1111/hel.12749

    [6]

    Ren S, Cai P, Liu Y, et al. Prevalence of Helicobacter pylori infection in China: A systematic review and meta-analysis[J]. J Gastroenterol Hepatol, 2022, 37(3): 464-470. doi: 10.1111/jgh.15751

    [7]

    She X, Zhao J, Cheng S, et al. Prevalence of and risk factors for Helicobacter pylori infection in rural areas of Northwest China: A cross-sectional study in two villages of Yan'an city[J]. Clin Epidemiol Glob Health, 2023, 21: 101294. doi: 10.1016/j.cegh.2023.101294

    [8]

    Javed S, Nadeem K, Zahid M. Prospects of mesenteric lymphadenopathy in children with chronic abdominal pain(CAP)[J]. Professional Med J, 2022, 29(6): 818-822. doi: 10.29309/TPMJ/2022.29.06.6958

    [9]

    Kulshrestha V, Tomar P, Kumar S. Clinico-imaging and pathological correlation in cases of mesenteric lymphadenitis presented as abdominal pain in children age group at Tertiary Care Hospital, Uttar Pradesh State, India[J]. Int J Acad Med Pharm, 2022, 4(3): 124-129.

    [10]

    Yuan C, Adeloye D, Luk T, et al. The global prevalence of and factors associated with Helicobacter pylori infection in children: a systematic review and meta-analysis[J]. Lancet Child Adolesc Health, 2022, 6(3): 185-194. doi: 10.1016/S2352-4642(21)00400-4

    [11]

    Nasri P, Saneian H, Famouri F, et al. Helicobacter pylori infection in pediatrics with gastrointestinal complaints[J]. Int J Physiol Pathophysiol Pharmacol, 2022, 14(2): 118-123.

    [12]

    Che H, Nguyen C, Vu T, et al. Factors associated with Helicobacter pylori infection among school-aged children from a high prevalence area in Vietnam[J]. Int J Public Health, 2023, 68: 1605908. doi: 10.3389/ijph.2023.1605908

    [13]

    Zhou Z, Lyu H, Zhu Y, et al. Large-scale, national, family-based epidemiological study on Helicobacter pylori infection in China: the time to change practice for related disease prevention[J]. Gut, 2023, 72(5): 855-869. doi: 10.1136/gutjnl-2022-328965

    [14]

    Ravikumara M. Helicobacter pylori in children: think before you kill the bug[J]. Therap Adv Gastroenterol, 2023, 16: 17562848231177610. doi: 10.1177/17562848231177610

    [15]

    Kato S, Gold D, Kato A. Helicobacter pylori-associated iron deficiency anemia in childhood and adolescence-pathogenesis and clinical management strategy[J]. J Clin Med, 2022, 11(24): 7351. doi: 10.3390/jcm11247351

    [16]

    Gomes RR. Helicobacter pylori: A belittled cause of immune thrombocytopenic purpura(ITP)and role of Helicobacter pylori eradication therapy for treating ITP[J]. J Clin Res Case Stud, 2023, 1(2): 1-6.

    [17]

    Hussain A, Nisha T. A study on prevalence, type and severity of anemia in Helicobacter pylori infection with respect to RBC parameters in a tertiary care hospital[J]. Saudi J Pathol Microbiol, 2021, 6(3): 100-104. doi: 10.36348/sjpm.2021.v06i03.003

    [18]

    Song Y, Huang X, Yu G, et al. Pathogenesis of IgA vasculitis: an up-to-date review[J]. Front immunol, 2021, 12: 771619. doi: 10.3389/fimmu.2021.771619

    [19]

    Marginean D, Marginean O, Melit E. Helicobacter pylori-related extraintestinal manifestations-myth or reality[J]. Children, 2022, 9(9): 1352. doi: 10.3390/children9091352

    [20]

    钱木草. 超声在诊断小儿肠系膜淋巴结肿大中的价值与意义[J]. 影像研究与医学应用, 2022, 6(6): 136-138. https://www.cnki.com.cn/Article/CJFDTOTAL-YXYY202206046.htm

    [21]

    Fonnes S, Rasmussen T, Brunchmann A, et al. Mesenteric lymphadenitis and terminal ileitis is associated with Yersinia infection: a meta-analysis[J]. J Surg Res, 2022, 270: 12-21. doi: 10.1016/j.jss.2021.08.027

  • 加载中
计量
  • 文章访问数:  221
  • 施引文献:  0
出版历程
收稿日期:  2023-12-24
刊出日期:  2024-06-15

返回顶部

目录